ElectroCore has raised $36 million in a new round of equity and options financing, according to an SEC filing posted this week. The Basking Ridge, N.J.-based company is seeking an additional $29 million in the round to bring the total to $65 million. Funds raised so far have come from 31 unnamed investors, with the […]
Neuroscience tech developer ElectroCore said today it launched its gammaCore non-invasive vagus nerve stimulator, designed for the acute treatment of pain associated with episodic cluster headaches in adult patients, in the US. The Basking Ridge, N.J.-based company touted the device as the 1st non-invasive, hand-held vagus nerve stimulation device for the reduction of pain. The system […]
Neuroscience tech developer ElectroCore today released data from the ACT clinical trials exploring the use of its gammaCore non-invasive vagus nerve stimulator for treating patients with episodic cluster headaches. Results from the study were presented at the 59th Annual Scientific Meeting of the American Headache Society, the company said. The 250-patient studies evaluated the safety and efficacy of the […]
Neuroscience tech developer ElectroCore said today it won FDA clearance for its GammaCore non-invasive vagus nerve stimulator designed to treat pain associated with episodic cluster headaches. The GammaCore device is designed to transmit a mild electrical stimulation to the vagus nerve through the skin to reduce pain, the Basking Ridge, N.J.-based company said. The device is […]
ElectroCore raised $1.5 million in a new round of debt financing, according to an SEC filing posted today. ElectroCore is developing a range of non-invasive vagus nerve stimulation for the treatment of a number of conditions in neurology, psychiatry, gastroenterology and other fields, according to the company’s website. Initial focus for the company is a […]
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
JenaValve said this week that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific‘s (NYSE:BSX) Bayer Interventional business, as its new chief executive officer. Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. […]
August 19, 2014 by Arezu Sarvestani
ElectroCore said it tapped investment bank Piper Jaffray to help it court potential partners to commercialize the non-invasive vagus nerve stimulation treatment for headaches it’s developing.
A pair of nascent technology companies touting "electroceutical" treatments teamed up to develop wireless vagus nerve stimulation technology.